Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Attention Deficit and Hyperactivity Disorders|January 8, 2015
Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USAMeryl Brod, Lenard A Adler, Sarah Lipsius, et al.
Journal of Cellular Biochemistry|February 1, 2021
The transcriptional regulator Zfat is essential for maintenance and differentiation of the adipocytesShuhei Ishikura, Masayoshi Nagai, Toshiyuki Tsunoda, et al.
International Journal of Molecular Sciences|November 25, 2023
YBX1 Regulates Satellite II RNA Loading into Small Extracellular Vesicles and Promotes the Senescent PhenotypeMasatomo Chiba, Kenichi Miyata, Hikaru Okawa, et al.
Biomedical Reports|December 5, 2019
Analysis of the selection of CDK4/6 inhibitors based on experience using palbociclibMariko Kikuchi, Yoko Tanaka, Mitsuo Yokota, et al.
Case Reports in Pathology|June 7, 2017
Hybrid Desmoplastic/Follicular Ameloblastoma of the Mandible: A Case Report and Review of the LiteratureMasayasu Iwase, Airi Fukuoka, Yoko Tanaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2019
[A Case of Pulmonary Carcinoid That Has Regressed Spontaneously]Yoko Tanaka, Mai Fujinami, Kentaro Tago, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 5, 2012
[Autoimmunity to glycolytic enzyme in rheumatoid arthritis]Isao Matsumoto, Keiichi Iwanami, Yoko Tanaka, et al.
Biochemistry and Biophysics Reports|March 13, 2023
Blood levels of d-amino acids reflect the clinical course of COVID-19Shihoko Kimura-Ohba, Yoshitsugu Takabatake, Atsushi Takahashi, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2014
Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: an integrated analysis of 15 clinical trialsAngelo Camporeale, Vibeke Porsdal, Katrien De Bruyckere, et al.
International Journal of Hematology|December 23, 2003
Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smearsNorifumi Tsukamoto, Masamitsu Karasawa, Yoko Tanaka, et al.
Pageof 19